Publication | Open Access
Study protocol for a randomised, phase II, double-blind, experimental medicine study of obinutuzumab versus rituximab in ANCA-associated vasculitis: ObiVas
19
Citations
14
References
2024
Year
ISRCTN13069630.
| Year | Citations | |
|---|---|---|
Page 1
Page 1